Home | News | TCM | Reflexology | Acupuncture | Taiji | Qigong | Herbal Tea | Sino-western Joint | Products | Cases | Academic Exchange | Prevention | Activities | Forum | Community | Blog | About Us | Site Map

Taking Chinese Medicine
Treatment Guides
TCM Reflexology
Treatment Guides
TCM Acupuncture
Treatment Guides
TCM Herbal Tea
Treatment Guides
Thank you very much for your visit. It's our great honour to render you heath service with the timely art of self healing. We wish you enjoy excellent health.
Product Tea
  • Hypertension Formula
  • Anti-Cancer Formula
  • Health Care Formula
  • Arthritis Care Formula
  • Skin Revitalizing Formula..
  • Slim Formula(Traditional ..
  • Cholesterol/Eyes Care For..
  • Diabetes Formula
  • Migraine Formula
  • Constipation Formula
  • Detox/Purify Formula
  • Prostate Care Formula
  • Male Fertility Formula
  • Female Fertility Formula
  • Menopause Formula(Traditi..
  • Menstruation Formula
  • Sciatica Formula(Traditio..
  • Skin Disease Formula
  • Insomnia Formula
  • Lumbago Formula(Tradition..
  • Sinusitis Formula
  • Swelling Care Formula
  • Tinnitus Formula
  • Stone Relief Formula
  • Thyroids Formula
  • Stomach & ulcer Formula
  • Colitis Care Formula
  • Asthma Formula
  • Romance Formula
  • Haircome Formula
  • Cardiovascular Formula
  • Liver Protein Associated With Diabetes Risk In
    The presence of a protein expressed by the liver which inhibits insulin action may identify individuals more likely to develop type 2 diabetes, according to anew study released Tuesday by the Journal of the American Medical Association.

    Researchers led by Joachim Ix at University of California, San Diego, found that higher serum levels of a protein called fetuin-A, produced by liver cells, was associated with type 2 diabetes in humans, independent of other risk factors.

    "Higher fetuin-A was associated with a 1.7-fold increased risk of diabetes, when adjusted for other factors," said Ix. Despite compelling laboratory and animal data of the protein's role in insulin resistance, until now the association of fetuin-A with new development of type 2 diabetes had not been evaluated in humans, according to Ix. "On the basis of this study, fetuin-A might be considered as a novel therapeutic target for prevention or treatment of insulin resistance," he said.

    Type 2 diabetes is a metabolic disorder characterized by insulin resistance that has become a global epidemic. The increased prevalence of obesity is a major contributing factor; however diabetes does not develop in all obese individuals, and reasons why one individual develops type 2 diabetes while another dose not are largely unknown.

    Recent research shows that proteins from fat tissue called adipocytokines regulate the metabolism of blood sugar or glucose, and may ultimately prove to be a target for new diabetes therapies. In contrast, fetuin-A is produced in liver cells, and is secreted into blood. In laboratory studies, fetuin-A binds to the insulin receptor found in muscle and fat, resulting in insulin resistance -- the hallmark of diabetes. Preliminary data from a separate study of participants without diabetes had shown an association between fetuin-A and insulin resistance.

    In this study, the researchers measured levels of fetuin-A in 519 diabetes-free individuals aged 70 to 79 years, and followed them for development of diabetes for six years. Participants with the highest levels of fetuin-A showed a higher risk of developing diabetes, when compared to those with low levels. The association was not affected by levels of adipocytokines.

    If you have any question about health or health care, please leave message herehttp://net.zoosnet.net/LR/Chatpre.aspx?id=NET39826137.our expert will reply you

    .


    no information

    Copyright©2003,Guilin Sino-western Joint Hospital Chinese Medicine Advisory Department
    About Us | TCM | Reflexology | Acupuncture | Taiji | Qigong | Herbal Tea | Products | Advertise | Contact us | Links | Site Map
    Tel: +86-773-5820588
    Fax: +86-773-5845295
    E-mail: tcmadvisory@gx163.net tcmadvisory@yahoo.com
    GuiLin ICP No.06002452